Related Experiment Video
Updated: Feb 17, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.1K
Carbamazepine Induced Thrombocytopenia
Ruhi Kumar1, Sridhar Chivukula2, Goutham Reddy Katukuri2
1Intern, Department of General Medicine, Kasturba Medical College, Manipal, Karnataka, India.
Journal of Clinical and Diagnostic Research : JCDR
|December 7, 2017
Summary
Older antiepileptic drugs (AEDs) like carbamazepine can cause serious blood disorders, particularly in children. Careful monitoring for conditions such as thrombocytopenia is crucial when using these medications.
Area of Science:
- Hematology
- Pharmacology
- Neurology
Background:
- Antiepileptic drugs (AEDs) are frequently linked to hematological disorders.
- While fatal conditions like aplastic anemia are rare, common issues include anemia, thrombocytopenia, and neutropenia.
- Older AEDs show a higher association with these blood disorders compared to newer agents.
Observation:
- The exact mechanisms behind AED-induced hematological alterations remain unclear, with immune responses and drug pharmacology being proposed.
- Children appear more susceptible to these adverse effects than adults.
- A case involving a patient with congenital heart disease, brain abscess, and seizures on carbamazepine presented with thrombocytopenia.
Findings:
- Carbamazepine was identified as the cause of thrombocytopenia in the presented case.
- Discontinuation of carbamazepine and switching to an alternative AED was necessary.
Implications:
- This case highlights the importance of vigilant monitoring for hematological side effects, especially with older AEDs like carbamazepine.
- Further research into the mechanisms of AED-induced hematological disorders is warranted.
- Clinical practice should emphasize careful patient selection and monitoring, particularly in pediatric populations.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
01:20Antiepileptic Drugs: Potassium Channel Activators
711
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
711
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.3K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.3K
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.8K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.8K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
957
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
957
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
12
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
12